UMBRALISIB for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 18 adverse event reports in the FDA FAERS database where UMBRALISIB was used for B-cell lymphoma.
Most Reported Side Effects for UMBRALISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 47 | 16.0% | 2 | 5 |
| Nausea | 36 | 12.3% | 1 | 5 |
| Disease progression | 30 | 10.2% | 2 | 3 |
| Fatigue | 30 | 10.2% | 1 | 0 |
| Covid-19 | 16 | 5.5% | 3 | 13 |
| Nervous system disorder | 15 | 5.1% | 0 | 0 |
| Death | 14 | 4.8% | 14 | 4 |
| Asthenia | 13 | 4.4% | 1 | 2 |
| Off label use | 13 | 4.4% | 1 | 0 |
| Product dose omission issue | 12 | 4.1% | 0 | 3 |
| Anaemia | 11 | 3.8% | 0 | 0 |
| Decreased appetite | 11 | 3.8% | 1 | 2 |
| Pyrexia | 11 | 3.8% | 0 | 0 |
| Dizziness | 10 | 3.4% | 0 | 3 |
| Drug ineffective | 10 | 3.4% | 0 | 0 |
Other Indications for UMBRALISIB
Chronic lymphocytic leukaemia (66)
Non-hodgkin's lymphoma (50)
Follicular lymphoma (48)
Product used for unknown indication (42)
Diffuse large b-cell lymphoma (20)
Marginal zone lymphoma (20)
Lymphoma (9)
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
LENALIDOMIDE (3,474)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)